123 related articles for article (PubMed ID: 27329811)
21. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
22. Induction of cereblon by NF-E2-related factor 2 in neuroblastoma cells exposed to hypoxia-reoxygenation.
Lee KJ; Lee KM; Jo S; Kang KW; Park CS
Biochem Biophys Res Commun; 2010 Sep; 399(4):711-5. PubMed ID: 20691658
[TBL] [Abstract][Full Text] [Related]
23. The molecular mechanism of thalidomide analogs in hematologic malignancies.
Lindner S; Krönke J
J Mol Med (Berl); 2016 Dec; 94(12):1327-1334. PubMed ID: 27492707
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
Fuchs O
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):51-78. PubMed ID: 29788898
[TBL] [Abstract][Full Text] [Related]
25. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera.
Kim K; Lee DH; Park S; Jo SH; Ku B; Park SG; Park BC; Jeon YU; Ahn S; Kang CH; Hwang D; Chae S; Ha JD; Kim S; Hwang JY; Kim JH
Sci Rep; 2019 Dec; 9(1):19654. PubMed ID: 31873151
[TBL] [Abstract][Full Text] [Related]
26. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine.
Sato T; Ito T; Handa H
Front Cell Dev Biol; 2021; 9():629326. PubMed ID: 33777938
[TBL] [Abstract][Full Text] [Related]
27. Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival.
Xu Q; Hou YX; Langlais P; Erickson P; Zhu J; Shi CX; Luo M; Zhu Y; Xu Y; Mandarino LJ; Stewart K; Chang XB
BMC Cancer; 2016 May; 16():297. PubMed ID: 27142104
[TBL] [Abstract][Full Text] [Related]
28. Molecular Mechanisms of the Teratogenic Effects of Thalidomide.
Asatsuma-Okumura T; Ito T; Handa H
Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32414180
[TBL] [Abstract][Full Text] [Related]
29. Cereblon in health and disease.
Kim HK; Ko TH; Nyamaa B; Lee SR; Kim N; Ko KS; Rhee BD; Park CS; Nilius B; Han J
Pflugers Arch; 2016 Aug; 468(8):1299-309. PubMed ID: 27343012
[TBL] [Abstract][Full Text] [Related]
30. Modulation of cereblon levels by anti-myeloma agents.
Díaz-Rodríguez E; Pandiella A
Leuk Lymphoma; 2016; 57(1):167-76. PubMed ID: 25860244
[TBL] [Abstract][Full Text] [Related]
31. Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myeloma.
Tachita T; Kinoshita S; Ri M; Aoki S; Asano A; Kanamori T; Yoshida T; Totani H; Ito A; Kusumoto S; Komatsu H; Yamagata K; Kubo K; Tohkin M; Fukuda S; Iida S
Cancer Sci; 2020 Apr; 111(4):1333-1343. PubMed ID: 32061138
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of cereblon-based drugs.
Asatsuma-Okumura T; Ito T; Handa H
Pharmacol Ther; 2019 Oct; 202():132-139. PubMed ID: 31202702
[TBL] [Abstract][Full Text] [Related]
33. What is the functional role of the thalidomide binding protein cereblon?
Chang XB; Stewart AK
Int J Biochem Mol Biol; 2011; 2(3):287-94. PubMed ID: 22003441
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial cereblon functions as a Lon-type protease.
Kataoka K; Nakamura C; Asahi T; Sawamura N
Sci Rep; 2016 Jul; 6():29986. PubMed ID: 27417535
[TBL] [Abstract][Full Text] [Related]
35. p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates.
Nguyen TV; Li J; Lu CJ; Mamrosh JL; Lu G; Cathers BE; Deshaies RJ
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3565-3571. PubMed ID: 28320958
[TBL] [Abstract][Full Text] [Related]
36. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
Payne JL; Song C; Ding Y; Dhanyamraju PK; Bamme Y; Schramm JW; Desai D; Sharma A; Gowda C; Dovat S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138279
[TBL] [Abstract][Full Text] [Related]
37. Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.
Bjorklund CC; Lu L; Kang J; Hagner PR; Havens CG; Amatangelo M; Wang M; Ren Y; Couto S; Breider M; Ning Y; Gandhi AK; Daniel TO; Chopra R; Klippel A; Thakurta AG
Blood Cancer J; 2015 Oct; 5(10):e354. PubMed ID: 26430725
[TBL] [Abstract][Full Text] [Related]
38. An Ikaros Promoter Element with Dual Epigenetic and Transcriptional Activities.
Perotti EA; Georgopoulos K; Yoshida T
PLoS One; 2015; 10(7):e0131568. PubMed ID: 26135129
[TBL] [Abstract][Full Text] [Related]
39. Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation.
Ando H; Sato T; Ito T; Yamamoto J; Sakamoto S; Nitta N; Asatsuma-Okumura T; Shimizu N; Mizushima R; Aoki I; Imai T; Yamaguchi Y; Berk AJ; Handa H
iScience; 2019 May; 15():95-108. PubMed ID: 31055217
[TBL] [Abstract][Full Text] [Related]
40. [Discovery of the target for immunomodulatory drugs (IMiDs)].
Ito T; Ando H; Handa H
Rinsho Ketsueki; 2016 May; 57(5):556-62. PubMed ID: 27263779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]